Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models

The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans

(2013) Sonja Krohn et al.   Frontiers in Immunology

Current status of chemokine receptor inhibitors in development

(2012) Marcello Allegretti et al.   IMMUNOLOGY LETTERS

Site-Directed Mutagenesis of the CC Chemokine Binding Protein 35K-Fc Reveals Residues Essential for Activity and Mutations That Increase the Potency of CC Chemokine Blockade

(2011) G. E. White et al.   MOLECULAR PHARMACOLOGY

Targeting chemokine receptors in chronic inflammatory diseases: An extensive review

(2011) Pim J. Koelink et al.   PHARMACOLOGY & THERAPEUTICS

IgE, mast cells, basophils, and eosinophils

(2010) Kelly D. Stone et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Characterization of the Chemokine CXCL11-Heparin Interaction Suggests Two Different Affinities for Glycosaminoglycans

(2010) India C. Severin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pan-CC Chemokine Neutralization Restricts Splenocyte Egress and Reduces Inflammation in a Model of Arthritis

(2010) V. Buatois et al.   JOURNAL OF IMMUNOLOGY

Structural Basis of Chemokine Sequestration by a Tick Chemokine Binding Protein: The Crystal Structure of the Complex between Evasin-1 and CCL3

(2009) João M. Dias et al.   PLoS One

Ticks produce highly selective chemokine binding proteins with antiinflammatory activity

(2008) Maud Déruaz et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Immunomodulatory arsenal of nymphal ticks

(2008) K. PETERKOVÁ et al.   MEDICAL AND VETERINARY ENTOMOLOGY